Sinovac Biotech Ltd (NASDAQ:SVA)
| 0.00 Delayed Data As of Dec 30 |  0.00 / 0.00%Today’s Change | -- |||52-Week Range -- | -- Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 65.5M | 65.4M | 116.0M | 158.2M | |
| Short Term Investment Cash | -25.9M | 14.0K | 50.4M | 42.2M | ||
| Cash & Short Term Investments | 65.5M | 65.4M | 116.0M | 177.1M | ||
| Receivables | Receivables | 39.0M | 49.8M | 66.2M | 77.5M | |
| Inventories | Inventories | 18.7M | 14.1M | 19.6M | 25.1M | |
| Current Assets | Prepaid Expenses | 352.0K | -- | -- | -- | |
| Other Current Assets | 5.0M | 4.9M | 2.1M | 4.5M | ||
| Current Assets | 128.5M | 134.2M | 203.9M | 284.2M | ||
| Total Assets | Property, Plant and Equipment - Gross | 101.2M | 106.2M | 123.0M | 120.0M | |
| Depreciation | -36.9M | -38.4M | -46.1M | -48.6M | ||
| Other Assets | 9.6M | 8.8M | 9.1M | 8.4M | ||
| Total Assets | 203.0M | 211.4M | 299.2M | 369.8M | ||
| Liabilities | Accounts Payable | 1.7M | 1.8M | 6.8M | 5.5M | |
| Short Term Debt | 24.2M | 33.6M | 18.2M | 3.3M | ||
| Accrued Expenses | 9.6M | 8.6M | 32.6M | 26.8M | ||
| Other Current Liabilities | 25.2M | 22.3M | 50.5M | 43.1M | ||
| Other Liabilities | 58.0M | 66.3M | 92.5M | 58.2M | ||
| Total Liabilities | Long Term Debt | 756.0K | 9.4M | 21.9M | 10.6M | |
| Deferred Taxes | -593.0K | -452.0K | -9.3M | -5.8M | ||
| Other Liabilities | 756.0K | 2.9M | 3.1M | 3.0M | ||
| Total Liabilities | 59.5M | 78.7M | 117.6M | 71.9M | ||
| Equity | Minority Interest | -861.0K | -124.0K | -10.9M | -14.3M | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 123.3M | 115.8M | 151.2M | 253.4M | ||
| Total Shareholder Equity | 123.3M | 115.8M | 151.2M | 253.4M | ||
| Share Information | Common Shares Outstanding | 56.9M | 57.0M | 57.3M | 71.1M | |
| Addtl. Info. | No data currently available for this section. | |||||
